A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all...

por Eisner, Florian, Pichler, Martin, Goletz, Steffen, Stoeger, Herbert, Samonigg, Hellmut
Publicado 2015

Desmoid Tumor Treated with Polychemotherapy Followed by Imatinib: A Case Report and Review of the Literature

por Knechtel, Gudrun, Stoeger, Herbert, Szkandera, Joanna, Dorr, Katrin, Beham, Alfred, Samonigg, Hellmut
Publicado 2010

Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation

por Hofmann, Guenter, Bauernhofer, Thomas, Krippl, Peter, Lang-Loidolt, Doris, Horn, Sabine, Goessler, Walter, Schippinger, Walter, Ploner, Ferdinand, Stoeger, Herbert, Samonigg, Hellmut
Publicado 2006

Phase I study of TrasGEX, a glyco-optimised anti-HER2 monoclonal antibody, in patients with HER2-positive solid tumours

por Fiedler, Walter, Stoeger, Herbert, Perotti, Antonella, Gastl, Guenther, Weidmann, Jens, Dietrich, Bruno, Baumeister, Hans, Danielczyk, Antje, Goletz, Steffen, Salzberg, Marc, De Dosso, Sara
Publicado 2018

Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients

por Benezeder, Theresa, Tiran, Verena, Treitler, Alexandra A.N., Suppan, Christoph, Rossmann, Christopher, Stoeger, Herbert, Cote, Richard J., Datar, Ram H., Balic, Marija, Dandachi, Nadia
Publicado 2017

Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition

por Tiran, Verena, Lindenmann, Joerg, Brcic, Luka, Heitzer, Ellen, Stanzer, Stefanie, Tabrizi-Wizsy, Nassim Ghaffari, Stacher, Elvira, Stoeger, Herbert, Popper, Helmut H., Balic, Marija, Dandachi, Nadia
Publicado 2017

Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy

por Müller, Hannah Deborah, Posch, Florian, Suppan, Christoph, Bargfrieder, Ute, Gumpoldsberger, Melanie, Hammer, Robert, Hauser, Hubert, Dandachi, Nadia, Prein, Kurt, Stoeger, Herbert, Lax, Sigurd, Balic, Marija
Publicado 2019

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung

por Brcic, Luka, Stanzer, Stefanie, Krenbek, Dagmar, Gruber-Moesenbacher, Ulrike, Absenger, Gudrun, Quehenberger, Franz, Valipour, Arschang, Lindenmann, Joerg, Stoeger, Herbert, Al Effah, Mohamed, Fediuk, Melanie, Balic, Marija, Popper, Helmut H.
Publicado 2018

Molecular profiling of soft-tissue sarcomas with FoundationOne(®) Heme identifies potential targets for sarcoma therapy: a single-centre experience

por Scheipl, Susanne, Brcic, Iva, Moser, Tina, Fischerauer, Stefan, Riedl, Jakob, Bergovec, Marko, Smolle, Maria, Posch, Florian, Gerger, Armin, Pichler, Martin, Stoeger, Herbert, Leithner, Andreas, Heitzer, Ellen, Liegl-Atzwanger, Bernadette, Szkandera, Joanna
Publicado 2021

SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types

por Richtig, Georg, Aigelsreiter, Ariane, Schwarzenbacher, Daniela, Ress, Anna Lena, Adiprasito, Jan Basri, Stiegelbauer, Verena, Hoefler, Gerald, Schauer, Silvia, Kiesslich, Tobias, Kornprat, Peter, Winder, Thomas, Eisner, Florian, Gerger, Armin, Stoeger, Herbert, Stauber, Rudolf, Lackner, Carolin, Pichler, Martin
Publicado 2017

MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors

por Schwarzenbacher, Daniela, Klec, Christiane, Pasculli, Barbara, Cerk, Stefanie, Rinner, Beate, Karbiener, Michael, Ivan, Cristina, Barbano, Raffaela, Ling, Hui, Wulf-Goldenberg, Annika, Stanzer, Stefanie, Rinnerthaler, Gabriel, Stoeger, Herbert, Bauernhofer, Thomas, Haybaeck, Johannes, Hoefler, Gerald, Jahn, Stephan Wenzel, Parrella, Paola, Calin, George Adrian, Pichler, Martin
Publicado 2019

C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study

por Riedl, Jakob M., Barth, Dominik A., Brueckl, Wolfgang M., Zeitler, Gloria, Foris, Vasile, Mollnar, Stefanie, Stotz, Michael, Rossmann, Christopher H., Terbuch, Angelika, Balic, Marija, Niedrist, Tobias, Bertsch, Thomas, Stoeger, Herbert, Pichler, Martin, Olschewski, Horst, Absenger, Gudrun, Ficker, Joachim H., Gerger, Armin, Posch, Florian
Publicado 2020

Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34

por Bartsch, Rupert, Singer, Christian F., Pfeiler, Georg, Hubalek, Michael, Stoeger, Herbert, Pichler, Angelika, Petru, Edgar, Bjelic-Radisic, Vesna, Greil, Richard, Rudas, Margaretha, Muy-Kheng, Tea Maria, Wette, Viktor, Petzer, Andreas L., Sevelda, Paul, Egle, Daniel, Dubsky, Peter C., Filipits, Martin, Fitzal, Florian, Exner, Ruth, Jakesz, Raimund, Balic, Marija, Tinchon, Christoph, Bago-Horvath, Zsuzsanna, Frantal, Sophie, Gnant, Michael
Publicado 2021